In vitro to in vivo extrapolation, DDI risk assessment, and drug metabolism analysis.
8 tools in this suite
In vitro to in vivo extrapolation of hepatic clearance using well-stirred model
Predict in vivo clearance from microsomal stability half-life data
FDA static model R1/R2/R3 for CYP inhibition and induction risk classification
Calculate fraction unbound in microsomes for IVIVE correction
Calculate Km, Vmax, and CLint from Michaelis-Menten kinetics data
Evaluate P-glycoprotein efflux ratio from Caco-2 or MDCK transport data
Predict renal clearance from GFR, tubular secretion, and reabsorption
Determine Biopharmaceutics Classification System class from solubility and permeability